Cargando…
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482636/ https://www.ncbi.nlm.nih.gov/pubmed/36115830 http://dx.doi.org/10.1038/s41392-022-01185-7 |
| _version_ | 1784791498047356928 |
|---|---|
| author | Luo, Deyan Yang, Xiaolan Li, Tao Ning, Nianzhi Jin, Song Shi, Zhuangzhuang Gu, Hongjing Li, Deyu Gao, Yuwei Wang, Hui |
| author_facet | Luo, Deyan Yang, Xiaolan Li, Tao Ning, Nianzhi Jin, Song Shi, Zhuangzhuang Gu, Hongjing Li, Deyu Gao, Yuwei Wang, Hui |
| author_sort | Luo, Deyan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9482636 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94826362022-09-19 An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants Luo, Deyan Yang, Xiaolan Li, Tao Ning, Nianzhi Jin, Song Shi, Zhuangzhuang Gu, Hongjing Li, Deyu Gao, Yuwei Wang, Hui Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-09-17 /pmc/articles/PMC9482636/ /pubmed/36115830 http://dx.doi.org/10.1038/s41392-022-01185-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Luo, Deyan Yang, Xiaolan Li, Tao Ning, Nianzhi Jin, Song Shi, Zhuangzhuang Gu, Hongjing Li, Deyu Gao, Yuwei Wang, Hui An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants |
| title | An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants |
| title_full | An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants |
| title_fullStr | An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants |
| title_full_unstemmed | An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants |
| title_short | An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants |
| title_sort | updated rbd-fc fusion vaccine booster increases neutralization of sars-cov-2 omicron variants |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482636/ https://www.ncbi.nlm.nih.gov/pubmed/36115830 http://dx.doi.org/10.1038/s41392-022-01185-7 |
| work_keys_str_mv | AT luodeyan anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT yangxiaolan anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT litao anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT ningnianzhi anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT jinsong anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT shizhuangzhuang anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT guhongjing anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT lideyu anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT gaoyuwei anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT wanghui anupdatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT luodeyan updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT yangxiaolan updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT litao updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT ningnianzhi updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT jinsong updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT shizhuangzhuang updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT guhongjing updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT lideyu updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT gaoyuwei updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants AT wanghui updatedrbdfcfusionvaccineboosterincreasesneutralizationofsarscov2omicronvariants |